Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Amneal Pharmaceuticals, Inc. | Director | Class A Common Stock | 251K | $1.33M | $5.31 | May 10, 2024 | Direct |
Alkermes plc. | Director | Ordinary Shares | 27.3K | $658K | $24.10 | Jun 29, 2024 | Direct |
Alkermes plc. | Director | Non Qualified Stock Option (Right to Buy) | 17.5K | $537K | $30.72 | May 31, 2024 | Direct |
Amneal Pharmaceuticals, Inc. | Director | Restricted Stock Units | 0 | $0 | $5.31 | May 10, 2024 | Direct |
Alkermes plc. | Director | Restricted Stock Unit Award | 0 | Jun 29, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALKS | Alkermes plc. | Jun 29, 2024 | 3 | -$35.3K | 4 | Jul 1, 2024 | Director |
ALKS | Alkermes plc. | Jun 9, 2024 | 3 | -$22.2K | 4 | Jun 10, 2024 | Director |
ALKS | Alkermes plc. | May 31, 2024 | 9 | $34.1K | 4 | Jun 4, 2024 | Director |
AMRX | Amneal Pharmaceuticals, Inc. | May 10, 2024 | 2 | $0 | 4 | May 14, 2024 | Director |
AMRX | Amneal Pharmaceuticals, Inc. | May 2, 2024 | 1 | $0 | 4 | May 6, 2024 | Director |
ALKS | Alkermes plc. | Jul 7, 2023 | 3 | -$42.7K | 4 | Jul 10, 2023 | Director |
ALKS | Alkermes plc. | Jun 29, 2023 | 2 | $0 | 4 | Jun 30, 2023 | Director |
ALKS | Alkermes plc. | Jun 9, 2023 | 3 | -$28.4K | 4 | Jun 12, 2023 | Director |
AMRX | Amneal Pharmaceuticals, Inc. | May 9, 2023 | 3 | $0 | 4 | May 11, 2023 | Director |
ALKS | Alkermes plc. | Jul 7, 2022 | 2 | $0 | 4 | Jul 8, 2022 | Director |
ALKS | Alkermes plc. | Jun 14, 2022 | 3 | -$24.6K | 4 | Jun 16, 2022 | Director |
ALKS | Alkermes plc. | Jun 9, 2022 | 6 | -$9.76K | 4 | Jun 10, 2022 | Director |
AMRX | Amneal Pharmaceuticals, Inc. | May 8, 2022 | 3 | $0 | 4 | May 10, 2022 | Director |
ALKS | Alkermes plc. | Aug 23, 2021 | 1 | $49.9K | 4 | Aug 24, 2021 | Director |
ALKS | Alkermes plc. | Jun 14, 2021 | 2 | $0 | 4 | Jun 16, 2021 | Director |
ALKS | Alkermes plc. | Jun 9, 2021 | 4 | $0 | 4 | Jun 11, 2021 | Director |
ALKS | Alkermes plc. | May 18, 2021 | 0 | $0 | 3 | May 28, 2021 | Director |
AMRX | Amneal Pharmaceuticals, Inc. | May 5, 2021 | 3 | $0 | 4 | May 7, 2021 | Director |